Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

Rhea-AI Summary

Quanterix Corporation (NASDAQ: QTRX) announced it will release its fourth quarter 2021 financial results on March 1, 2022, prior to market opening. A conference call hosted by CEO Kevin Hrusovsky will take place at 8:30 a.m. EST to discuss the results and provide a business update. Interested parties can participate via phone or listen to a live webcast. Quanterix focuses on digitizing biomarker analysis to enhance precision health, aiming for early disease detection and improved treatments.

Positive

• Anticipation of financial results release may indicate potential positive performance.
• Focus on digitizing biomarker analysis aligns with growing precision health sector.

Negative

• None.

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will release its financial results for fourth quarter 2021 before the start of trading on Tuesday, March 1, 2022. Company management will host a conference call at 8:30 a.m. EST to discuss Quanterix’ financial results and provide a business update. The call will be hosted by Kevin Hrusovsky, Chairman and Chief Executive Officer, Quanterix.

Individuals interested in listening to the conference call may do so by dialing (833) 686-9351 for domestic callers, or (612) 979-9890 for international callers. Please reference the following Conference ID: 5230769. A live webcast will also be available at: https://edge.media-server.com/mmc/p/udpgv5ou. You may also access the live webcast by visiting the News & Events page within the Investors section of the Quanterix website at www.quanterix.com. The webcast will be available on the Company’s website for one year following completion of the call.

About Quanterix

Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. For additional information, please visit https://www.quanterix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220223006212/en/

Media Contact:

PAN Communications

Paige Romine, 321-652-8370

pan.quanterix@pancomm.com



Investor Relations Contact:

Stephen Hrusovsky

(774) 278-0496

shrusovsky@quanterix.com

Source: Quanterix Corporation

FAQ

When will Quanterix release its Q4 2021 financial results?

Quanterix will release its Q4 2021 financial results on March 1, 2022.

Who will host the Quanterix Q4 2021 earnings call?

The earnings call will be hosted by Kevin Hrusovsky, CEO of Quanterix.

What is the purpose of the Quanterix conference call on March 1, 2022?

The conference call will discuss the financial results and provide a business update.

What technology does Quanterix focus on?

Quanterix focuses on digitizing biomarker analysis to enhance precision health.